companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

YASKIW FEED SVC

BIRTLE-Canada

Company Name:
Corporate Name:
YASKIW FEED SVC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: NW 33 17 26,BIRTLE,MB,Canada 
ZIP Code:
Postal Code:
R0M0C0 
Telephone Number: 2048425252 
Fax Number: 2048425252 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
519112 
USA SIC Description:
Feed-Dealers (Wholesale) 
Number of Employees:
1 to 4 
Sales Amount:
$2.5 to 5 million 
Credit History:
Credit Report:
Very Good 
Contact Person:
Stan Yaskiw 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
BMB ENTERPRISE LTD
BIRSAY PORK FARMS INC
BIRSAY KITCHEN
Next company profile:
WORLD TRADE ENTERPRISES
WORLD TRADE ENTERPRISES
WEYBURN INLAND TERNIMAL LTD










Company News:
  • Microsoft Word - Egrifta SV BLA 022505 S-018 final PI
    The recommendations in this prescribing information only apply to EGRIFTA SV (tesamorelin) for injection 2 mg per vial formulation For recommendations for tesamorelin for injection 1 mg per vial formulation, see the EGRIFTA prescribing information
  • EGRIFTA® (tesamorelin for injection), for subcutaneous use
    These highlights do not include all the information needed to use EGRIFTA (2 mg vial) safely and effectively See full prescribing information for EGRIFTA (2 mg vial)
  • Egrifta: Package Insert Prescribing Information MOA
    Egrifta package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    EGRIFTA SV for injection is supplied in a single-dose 2 mg vial as a white to off-white lyophilized powder and a diluent of 10 mL of Sterile Water for Injection, USP
  • EGRIFTA WR
    For complete disclosure of EGRIFTA WR TM product information, please read the Full Prescribing Information, Patient Information, and Patient Instructions for Use
  • Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamore
    Further information about EGRIFTA WR™, including full prescribing information, instructions for use, and important safety information is available here Important Safety Information
  • label - accessdata. fda. gov
    This Patient Information leaflet summarizes the most important information about EGRIFTA® If you would like more information, talk with your healthcare provider
  • Dosing Administration - EGRIFTA SV
    The impact and safety of EGRIFTA SV ® on cardiovascular health have not been studied EGRIFTA SV ® is not indicated for weight loss management It is not known whether taking EGRIFTA SV ® helps improve compliance with anti‑retroviral medications
  • Resources for You and Your Patients - hcp. egriftawr. com
    Learn about the EGRIFTA WR TM mechanism of action, key data, dosing and administration, and more Provide patients with information about EGRIFTA WR TM and why it could be an option for them Help patients have informed conversations with their doctor about EVAF and EGRIFTA WR TM therapy
  • label - accessdata. fda. gov
    For recommendations for tesamorelin for injection 2 mg per vial formulation, see the EGRIFTA SV prescribing information These two formulations and strengths have differences in the dosage,




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer